George Eric Davis - 08 Aug 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Reporting relationship: EVP, Chief Legal Officer
Issuer ticker: BMRN
Reported as of: 08 Aug 2023
Net transaction value: -$983,662
SEC form: 4
Accepted by SEC: 09 Aug 2023, 19:08:32 UTC
Prior SEC filing: 18 May 2023
Next SEC filing: 14 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Eric Fleekop, Attorney-in-Fact

Key filing fact

George Eric Davis filed Form 4 for BIOMARIN PHARMACEUTICAL INC (BMRN) on 09 Aug 2023.

Key facts

This page summarizes George Eric Davis's Form 4 filing for BIOMARIN PHARMACEUTICAL INC (BMRN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Aug 2023, 19:08.

Change

Previous filing in this sequence was filed on 18 May 2023.
Current net transaction value: -$983,662.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMRN transaction

Common Stock

Sale

Transaction value: $983,662
Shares: -11,000
Change %: -14%
Price: $89.42
Shares after: 69,474
Date: 08 Aug 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price in column 4 is the weighted average price. The price actually received ranged from $89.39 to $89.52. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.